Pfizer (PFE) Dividends payables (2009 - 2026)

Pfizer (PFE) has reported Dividends payables for 18 consecutive years, with $2.5 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Dividends payables changed 0.25% year-over-year to $2.5 billion in Q2 2026; TTM through Jun 2026 was $2.5 billion, a 0.25% change from a year earlier, with the FY2025 full-year figure at $2.4 billion, changed 0.33% from the prior year.
• Dividends payables was $2.5 billion for Q2 2026 at Pfizer, roughly flat from $2.4 billion in the prior quarter.
• Over five years, Dividends payables peaked at $2.5 billion in Q2 2026 and troughed at $2.2 billion in Q3 2022.
• A 5-year average of $2.4 billion and a median of $2.4 billion in 2024 frame the typical range for Dividends payables.
• Across the five-year window, Dividends payables gained 3.12% in 2023 and rose 0.25% in 2026, its largest moves.
• Over 5 years, Dividends payables stood at $2.3 billion in 2022, then grew by 3.0% to $2.4 billion in 2023, then gained by 2.74% to $2.4 billion in 2024, then increased by 0.33% to $2.4 billion in 2025, then rose by 0.25% to $2.5 billion in 2026.
• The last three Dividends payables figures came in at $2.5 billion (Q2 2026), $2.4 billion (Q4 2025), and $2.4 billion (Q2 2025), per Business Quant data.